Which closed-end funds own Moderna Inc?
7 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $48.7M. Security type: common equity. Country: United States. CUSIP 60770K107 · ISIN US60770K1079 · ticker MRNA.
Holdings are historical filings (report dates May 29, 2026 – Jun 30, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| BMEZ BlackRock Health Sciences Term Trust | Healthcare | 3.56% | $38.5M | 549,814 sh | $1.1B | NAV unavailable | Jun 30, 2026 |
| BME BlackRock Health Sciences Trust | Healthcare | 0.99% | $5.7M | 81,325 sh | $573M | 3.7% discount | Jun 30, 2026 |
| ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund | Covered Call / Option Income | 0.15% | $2.8M | 40,268 sh | $1.8B | 9.7% discount | Jun 30, 2026 |
| ETW Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund | Covered Call / Option Income | 0.06% | $703K | 10,045 sh | $1.2B | 11.2% discount | Jun 30, 2026 |
| GAB Gabelli Equity Trust | U.S. Equity | 0.04% | $840K | 12,000 sh | $2.4B | 6.5% discount | Jun 30, 2026 |
| GUG Guggenheim Active Allocation Fund | U.S. Equity | 0.01% | $87.3K | 1,850 sh | $631M | 14.1% discount | May 29, 2026 |
| GOF Guggenheim Strategic Opportunities Fund | Multi-Asset | 0.00% | $15.5K | 328 sh | $2.8B | 12.9% discount | May 29, 2026 |
7 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Also listed in filings as: MODERNA INC.
Issuer-level search for “MRNA” → · Compare two funds’ portfolios →